Surface Oncology Inc (SURF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Operating Expenses | 25,641 | 19,663 | 21,183 | 22,898 | 24,624 |
| Operating Income | -25,641 | -19,663 | -21,183 | -22,898 | -24,624 |
| Other Income | -2,551 | -78 | -149 | -342 | -589 |
| Pre-tax Income | -28,192 | -19,741 | -21,332 | -23,240 | -25,213 |
| Net Income Continuous | -28,192 | -19,741 | -21,332 | -23,240 | -25,213 |
| Net Income | $-28,192 | $-19,741 | $-21,332 | $-23,240 | $-25,213 |
| EPS Basic Total Ops | -0.46 | -0.33 | -0.42 | -0.39 | -0.46 |
| EPS Basic Continuous Ops | -0.46 | -0.33 | -0.41 | -0.39 | -0.46 |
| EPS Diluted Total Ops | -0.46 | -0.33 | -0.42 | -0.39 | -0.46 |
| EPS Diluted Continuous Ops | -0.46 | -0.33 | -0.41 | -0.39 | -0.46 |
| EPS Diluted Before Non-Recurring Items | -0.41 | -0.33 | -0.35 | -0.39 | -0.46 |
| EBITDA(a) | $-23,729 | $-19,479 | $-20,974 | $-22,563 | $-24,180 |